7 completed, 1 recruiting, 1 unknown, 1 withdrawn. 10 Phase 3, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 10 | Completed 7, Recruiting 1, Unknown 1, Withdrawn 1 |
| Phase 2 | 4 | Completed 3, Unknown 1 |
Follow Blood Transfusion: new trials by email Literature Review of Blood Transfusion trials Research Report on Blood Transfusion
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Indication Based Blood Product Transfusion in Patients Undergoing Major Oncological Surgery blood volume loss based blood transfusion, hemoglobin concentration based blood transfusion - Blood Transfusion | Phase 2 / Phase 3 | Unknown | Second Affiliated Hospital, Zhejiang University, School of Medicine | 260 | 2023-01-01 | 2022-11-07 |
| Management of Shock in Children With SAM or Severe Underweight and Diarrhea Blood and Dopamine, Blood and adrenaline - Shock Hypovolemic, Shock, Septic | Phase 3 | Recruiting | International Centre for Diarrhoeal Disease Research, Bangladesh | 135 | 2021-08-17 | 2025-04-16 |
| A Study to Determine an Effective Dose of Epoetin Alfa to Decrease the Number of Units of Blood Required to be Transfused During Hip Replacement Surgery. epoetin alfa - Anemia, Blood Transfusion | Phase 3 | Withdrawn | Janssen-Ortho Inc., Canada | 1996-05-01 | 2016-09-20 | |
| A Study to Determine Whether Epoetin Alfa Can Reduce the Need for Blood Transfusions in Patients During the Period of Time Around Major Orthopedic Surgery. epoetin alfa - Anemia, Blood Transfusion | Phase 3 | Completed | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 316 | 1993-04-01 | 2011-05-18 |
| A Study to Determine the Safety and Effectiveness of Epoetin Alfa in Facilitating Self-donation of Blood Before Surgery in Patients Who Are Not Anemic and Who Will be Undergoing Orthopedic or Heart and Blood Vessel Surgery epoetin alfa - Blood Transfusion, Blood Transfusion, Autologous | Phase 2 / Phase 3 | Completed | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 80 | 1990-01-01 | 2011-05-18 |
| Trial to Reduce Alloimmunization to Platelets (TRAP) platelet transfusion - Blood Platelets, Hematologic Diseases | Phase 3 | Completed | National Heart, Lung, and Blood Institute (NHLBI) | 1989-08-01 | 2016-11-07 | |
| Transfusion-Transmitted Cytomegalovirus Prevention in Neonates immunoglobulins - Blood Transfusion, Cytomegalovirus Infections | Phase 3 | Completed | National Heart, Lung, and Blood Institute (NHLBI) | 1983-07-01 | 2013-11-26 | |
| Granulocyte Transfusion Study leukocyte transfusions - Blood Transfusion, Infection | Phase 3 | Completed | National Heart, Lung, and Blood Institute (NHLBI) | 1976-09-01 | 2013-11-26 | |
| A Study to Determine the Effectiveness of Epoetin Alfa in Facilitating Self-donation of Blood Before Surgery in Non-anemic Patients Who Are Undergoing Orthopedic, Heart and Blood Vessel, or Breast Reduction Surgery; Performed in Combination With a Procedure to Reduce Blood Loss During Surgery. epoetin alfa - Blood Transfusion, Blood Transfusion, Autologous | Phase 2 / Phase 3 | Completed | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 112 | 2011-05-18 | |
| A Study of the Safety and Effectiveness of Epoetin Alfa in Facilitating Self-donation of Blood Before Surgery in Patients Who Are Undergoing Orthopedic Surgery and Who Have Low Hematocrit Levels (the Percent of Red Blood Cells in Whole Blood) epoetin alfa - Anemia, Blood Transfusion | Phase 2 / Phase 3 | Completed | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 55 | 2011-05-18 |
Anemia (3) · Cholera (1) · Cytomegalovirus Infections (1) · Hematologic Diseases (1) · Infections (1) · Leukemia, Myeloid, Acute (1) · Severe Acute Malnutrition (1) · Shock (1) · Shock, Septic (1) · Thinness (1)
Hemic and Lymphatic Diseases (4) · Hematologic Diseases (3) · Infections (2) · Bacterial Infections (1) · Bacterial Infections and Mycoses (1) · Body Weight (1) · DNA Virus Infections (1) · Gram-Negative Bacterial Infections (1) · Herpesviridae Infections (1) · Inflammation (1) · Leukemia (1) · Leukemia, Myeloid (1) · Malnutrition (1) · Neoplasms (1) · Neoplasms by Histologic Type (1)
Epoetin Alfa (5) · Blood Specimen Collection (1) · Dopamine (1) · Epinephrine (1) · Immunoglobulins (1) · Leukocyte Transfusion (1) · Platelet Transfusion (1)
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (4) · National Heart, Lung, and Blood Institute (NHLBI) (3) · International Centre for Diarrhoeal Disease Research, Bangladesh (1) · Janssen-Ortho Inc., Canada (1) · Second Affiliated Hospital, Zhejiang University, School of Medicine (1)
Bangladesh (1)
Charles Schiffer (1) · Geoffrey Herzig (1) · Hayden Braine (1) · Janice McFarland (1) · Jeffrey McCullough (1) · Kuo-Jang Kao (1) · Robert Gale (1) · Ronald Strauss (1) · Sherrill Schlichter (1) · Tahmeed Ahmed, PhD (1) · Xiaobo Yan, MD (1)
PMID 10371570, PMID 1632474, PMID 19593244, PMID 21615299, PMID 21627690, PMID 23496872, PMID 24196006, PMID 24661049, PMID 26323041, PMID 26440279, PMID 27673385, PMID 28144779, PMID 28316439, PMID 28509730, PMID 29318195, PMID 30065491, PMID 31821418, PMID 32032273, PMID 37045565, PMID 8194289, PMID 9842034
U01HL042824 (1)